Michael Volker

Title: Michael Volker: Innovator in Liver Fibrosis Diagnosis

Introduction

Michael Volker is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the assessment of liver fibrosis. His innovative approach combines various diagnostic markers to enhance the accuracy of liver disease diagnosis.

Latest Patents

Michael Volker holds a patent for a method titled "Assessment of liver fibrosis scoring with serum marker algorithms." This invention involves measuring two or more diagnostic markers and correlating these measurements through a mathematical algorithm. The diagnostic markers utilized in this method include N-terminal procollagen III propeptide (PIIINP), Collagen IV, Collagen VI, Tenascin, Laminin, Hyaluronan, MMP-2, TIMP-1, and the MMP-9/TIMP-1 complex. The algorithm is designed to predict the histological score of a liver biopsy, thereby improving diagnostic accuracy.

Career Highlights

Throughout his career, Michael Volker has focused on advancing medical diagnostics. His work has led to the development of innovative methods that aid in the early detection and assessment of liver conditions. With a patent count of 1 patent, he continues to contribute to the medical field through his research and inventions.

Collaborations

Michael Volker has collaborated with esteemed colleagues, including Michael Becka and Werner Kroll. These partnerships have fostered a collaborative environment that enhances the development of innovative diagnostic solutions.

Conclusion

Michael Volker's contributions to liver fibrosis diagnosis exemplify the impact of innovation in medical technology. His patented method represents a significant advancement in the field, showcasing the importance of combining diagnostic markers for improved patient outcomes.